Organizing Committee
OCM Member
Albert Einstein College of Medicine , USA
Biography :

Dr. Katz comes to Montefiore and Einstein from both academic medicine and industry, where he has been most recently engaged in the biotech arena and drug development for several years. He served as CEO of Danube Pharmaceuticals and chief medical officer of both Fovea Pharmaceuticals and Eyetech, which brought the first medical therapy for macular degeneration to market. Prior to that, he had a distinguished career in academia, most recently as professor and chairman of the Department of Ophthalmology at the George Washington University School of Medicine. Over the course of his 25-year career, Dr. Katz has earned a reputation as a gifted clinician and teacher as well as an accomplished researcher. He also served as co-director of a joint fellowship in ophthalmologic drug development, regulation and trials co-sponsored by George Washington University and the U.S. Food and Drug Administration. As a neuro-ophthalmologist, Dr. Katz’s clinical expertise is in treatment of optic nerve diseases, unusual eye movements, and ocular manifestations of systemic diseases. He has joint appointments in the departments of ophthalmology, neurology, and neurosurgery at Montefiore and Einstein. Dr. Katz received his medical degree from Case-Western Reserve University School of Medicine. He completed an internship in medicine at Parkland Hospital in Dallas, served as a research staff associate in neuro-virology at the National Institutes of Health, completed a residency in neurology at Harvard University and an ophthalmology residency at Tufts-New England Medical Center. He completed fellowships at Harvard, at the National Hospital for Nervous Disease at Queen’s Square in London, and at the University of California, San Francisco (UCSF). Dr. Katz obtained an M.B.A. in finance and healthcare management from the University of Rochester’s Simon School of Business, and has served on the faculties of the University of California, San Diego, UCSF, and the University of Rochester. Dr. Katz has authored numerous articles published in peer reviewed journals, and has served on the board of directors for professional societies including the Ophthalmology Research and Education Foundation and the International Eye Foundation. He resides in New York City.

Research Interest :

Neurology , Tardive Dyskinesia

OCM Member
Moscow Helmholtz Research Institute of Eye Diseases , Russian Federation
Biography :

Professor of Pathophysiology Marina Zueva graduated from the Lomonosov Moscow State University (Physiology of Higher Nervous Activity). She received her Ph.D. degree in 1980 and then the degree of Doctor of Biol Sci in 1997 from Moscow Helmholtz Research Institute of Eye Diseases. From 1973 to present time she works in the Department of Clinical Physiology of Vision at Moscow Helmholtz Research Institute of Eye Diseases. Current position - the Head of the Department. In 2017, she founded and became a General Director of the LTD “Center of Neurocognitive Technologies “Cognito”.” Marina Zueva is a member of International Society of Clinical Electrophysiology of Vision (ISCEV), European Association for Vision and Eye Research (EVER), European Society of Retina Specialists (EURETINA) and some other scientific Societies. She has published over 15 peer-reviewed papers in English and over 100 in Russian, 13 Chapters in the books (one – in English) and presented over 70 topics at international conferences. Research Topics: Basic and clinical physiology and electrophysiology of vision, neurophysiology; Age-related, developmental and neurodegenerative disorders of the visual system and brain, neurocognitive technologies in the diagnosis and treatment of diseases of the retina and brain.

Research Interest :

Basic and clinical physiology and electrophysiology of vision, neurophysiology; Age-related, developmental and neurodegenerative disorders of the visual system and brain, neurocognitive technologies in the diagnosis and treatment of diseases of the retina and brain.

OCM Member
Department head, Neurology
University of Buenos Aires , Argentina
Biography :

Dr. Federico Micheli is currently the Head of the Neurology Degree Department of the University of Buenos Aires and also Professor of Neurology, University of Buenos Aires. Dr. Federico Micheli has published 23 books and 48 chapters under his name and also holds 11 national journal publications and 120 international journals in the last 15 years.

Research Interest :

Neurology , Tardive Dyskinesia

OCM Member
National Chemical Laboratory , India
Biography :

Dr. Subashchandrabose Chinnathambi obtained his Ph.D. in Biochemistry from Max Planck Institute for Structural Molecular Biology (MPGASMB), Hamburg, Germany in 2011. He has examined the Influence of Phosphorylation on the Pathological Conformation of Human Microtubule-Associated Protein Tau in Alzheimer’s disease. His post-doctoral training at the German Center for Neurodegeneration Disease (DZNE)–Bonn and Max Planck Institute for Neurobiological Research-Cologne, Germany, studied the role of rare MAPT (p. A152T mutant) mutation increases the pathological conformation and physiological properties of Tau (axonal protein) in Alzheimer’s patient. After the post-doctoral stint he joined as a Scientist at the Biochemical Sciences Division, National Chemical Laboratory (CSIR-NCL). In last three years, he established a neurobiology research group at CSIR-NCL; he is currently focusing on signaling cascades and post-translational modifications of Tau (Alzheimer’s) and Alpha Synuclein (Parkinson’s) disease. He has expertise in the area of neurochemistry and especially on Alzheimer’s disease

Research Interest :

Basic and clinical physiology and electrophysiology of vision, neurophysiology; Age-related, developmental and neurodegenerative disorders of the visual system and brain, neurocognitive technologies in the diagnosis and treatment of diseases of the retina and brain.

Copyright © 2017-2018 Allied Academies, All Rights Reserved.